TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma
Clinical trial NCT04988945 · RECRUITING
Trial details
- NCT number
- NCT04988945
- Sponsor
- The University of Hong Kong
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2024-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.